Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

The dermatology market in the U.S. is at a pivotal moment of transformation, with spending poised to climb from $40.55 billion in 2023 to $70 billion by 2030. This unprecedented growth mirrors past ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

However, a 2019 study that included 63,443 women with eczema found that gluten was not a dietary risk factor for eczema. In other words, eating more or less gluten had no effect on symptoms.